Association between papillary thyroid carcinoma and lymphocytic thyroiditis: A retrospective study

被引:4
作者
Wu, Kai [1 ,2 ]
Shi, Liuhong [2 ]
Wang, Jianbiao [2 ]
Xie, Lei [2 ,3 ]
机构
[1] Linping Dist First Peoples Hosp, Dept Otorhinolaryngol, Hangzhou 311100, Zhejiang, Peoples R China
[2] Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Head & Neck Surg, Sch Med, Hangzhou 310016, Zhejiang, Peoples R China
[3] Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Head & Neck Surg, Sch Med, 3 East Qingchun Rd, Hangzhou 310016, Zhejiang, Peoples R China
关键词
papillary thyroid carcinoma; lymphocytic thyroiditis; central lymph node metastasis; Hashimoto's thyroiditis; histopathological specimens; METASTATIC LYMPH-NODES; DISEASE-FREE SURVIVAL; HASHIMOTOS-THYROIDITIS; NODAL METASTASES; RISK-FACTORS; CANCER; MULTIFOCALITY; EXPRESSION; BILATERALITY; INFILTRATION;
D O I
10.3892/ol.2023.13734
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aim of the present study was to evaluate the association between coexisting lymphocytic thyroiditis (LT) and the clinicopathological features of papillary thyroid carcinoma (PTC). The records of 458 patients with PTC who underwent a total thyroidectomy and lymph node dissection in Sir Run Run Shaw Hospital (Hangzhou, China) were analyzed. In accordance with the histopathology of thyroid parenchyma, the cases were divided into three groups, including Hashimoto's thyroiditis (HT), non-Hashimoto's type LT (NHLT) and no LT. Based on the histopathology, data on age, sex, maximum diameter of tumor, multifocality, extrathyroidal extension, metastatic lymph node size, extranodal extension and tumor grades in the different groups were analyzed and compared. The prevalence of coexisting LT was 29.0% (133/458), of which 7.6% (35/458) was HT and 21.4% (98/458) was NHLT. PTC concomitant with LT was significantly associated with female patients (95.5 vs. 70.2%; P<0.001), a lower rate of extrathyroidal extension and/or capsular invasion (25.6 vs. 39.7%; P=0.004), central lymph node metastasis (CLNM) ratio (10.71 vs. 17.37; P=0.014), higher number of dissected central lymph nodes (16.83 vs. 11.7; P<0.001), larger metastatic lymph nodes (0.66 vs. 0.46 cm; P<0.001), higher occurrence of multifocality (61.7 vs. 50.5%; P=0.029) and earlier pT stage (57.9 vs. 38.8%; P<0.001), regardless of the combined or separate consideration of HT and NHLT. Besides, LT was associated with multifocality [odds ratio (OR), 1.578; 95% confidence interval (CI), 1.046-2.382; P=0.030]. Furthermore, in patients with PTC, CLNM had a significant association with the male sex (OR, 2.000; 95% CI, 1.216-3.288; P=0.006), an age of <45 years (OR, 0.592; 95% CI, 0.398-0.879; P=0.009) and a tumor size of >1 cm (OR, 3.913; 95% CI, 2.431-5.734; P<0.001). In conclusion, patients with PTC and LT showed a greater female preponderance, multifocality, a lower extrathyroidal extension and a lower CLNM ratio. LT was associated with an increased risk of multifocality in PTC.
引用
收藏
页数:9
相关论文
共 50 条
[1]   Multifocal Papillary Thyroid Cancer Increases the Risk of Central Lymph Node Metastasis [J].
Al Afif, Ayham ;
Williams, Blair A. ;
Rigby, Mathew H. ;
Bullock, Martin J. ;
Taylor, S. Mark ;
Trites, Jonathan ;
Hart, Robert D. .
THYROID, 2015, 25 (09) :1008-1012
[2]   Size Distribution of Metastatic Lymph Nodes with Extranodal Extension in Patients with Papillary Thyroid Cancer: A Pilot Study [J].
Alpert, Erin H. ;
Wenig, Bruce M. ;
Dewey, Eliza H. ;
Su, Henry K. ;
Dos Reis, Laura ;
Urken, Mark L. .
THYROID, 2015, 25 (02) :238-241
[3]   Hashimoto's Thyroiditis Is Not Associated with Increased Risk of Thyroid Cancer in Patients with Thyroid Nodules: A Single-Center Prospective Study [J].
Anil, Cueneyd ;
Goksel, Sibel ;
Gursoy, Alptekin .
THYROID, 2010, 20 (06) :601-606
[4]   Hashimoto's thyroiditis shares features with early papillary thyroid carcinoma [J].
Arif, S ;
Blanes, A ;
Diaz-Cano, SJ .
HISTOPATHOLOGY, 2002, 41 (04) :357-362
[5]   The relationship between multiple intrathyroidal involvement in papillary thyroid carcinoma and chronic non-specific thyroiditis [J].
Asanuma, K ;
Sugenoya, A ;
Kasuga, Y ;
Itoh, N ;
Kobayashi, S ;
Amano, J .
CANCER LETTERS, 1998, 122 (1-2) :177-180
[6]   Role of cytotoxic T cells and PD-1 immune checkpoint pathway in papillary thyroid carcinoma [J].
Banerjee, Sohini ;
Nahar, Uma ;
Dahiya, Divya ;
Mukherjee, Soham ;
Dey, Pranab ;
Gupta, Rijuneeta ;
Radotra, Bishan ;
Sachdeva, Naresh ;
Sood, Ashwani ;
Bhadada, Sanjay Kumar ;
Bhansali, Anil .
FRONTIERS IN ENDOCRINOLOGY, 2022, 13
[7]   Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration [J].
Boelaert, K. ;
Horacek, J. ;
Holder, R. L. ;
Watkinson, J. C. ;
Sheppard, M. C. ;
Franklyn, J. A. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (11) :4295-4301
[8]   The Thyroid Gland: A Crossroad in Inflammation-Induced Carcinoma? An Ongoing Debate with New Therapeutic Potential [J].
Bozec, A. ;
Lassalle, S. ;
Hofman, V. ;
Ilie, M. ;
Santini, J. ;
Hofman, P. .
CURRENT MEDICINAL CHEMISTRY, 2010, 17 (30) :3449-3461
[9]   Immunohistochemical detection of p53 homolog p63 in solid cell nests, papillary thyroid carcinoma, and Hashimoto's thyroiditis: A stem cell hypothesis of papillary carcinoma oncogenesis [J].
Burstein, DE ;
Nagi, C ;
Wang, BY ;
Unger, P .
HUMAN PATHOLOGY, 2004, 35 (04) :465-473
[10]   Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer [J].
Cooper, David S. ;
Doherty, Gerard M. ;
Haugen, Bryan R. ;
Kloos, Richard T. ;
Lee, Stephanie L. ;
Mandel, Susan J. ;
Mazzaferri, Ernest L. ;
McIver, Bryan ;
Pacini, Furio ;
Schlumberger, Martin ;
Sherman, Steven I. ;
Steward, David L. ;
Tuttle, R. Michael .
THYROID, 2009, 19 (11) :1167-1214